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summary
A schistosome infection is initiated when the parasite penetrates the skin of a susceptible host. Relatively large quantities
of protein are released by transforming cercariae compared to later larval stages. This represents the first parasite material
to which the host’s immune system is exposed, yet little is known about the proteins which are released during the first
few hours post-transformation. We have shown that antiserum raised against such molecules was capable of imparting
protection against a schistosome challenge infection upon passive transfer to naı$ve mice. By screening a cercarial cDNA
library with this serum, 38 positive clones were identified. Sequence analysis showed these to represent 8 different
molecules which included Schistosoma mansoni 21–7 kDa antigen, calcium-binding-protein and the vaccine candidate
glutathione S-transferase (Sm28GST). In addition, 5 clones were isolated, 1 of which had significant homology to many
cytochrome C proteins, another with leukocyte elastase inhibitors and 3 which represented novel molecules. Four clones
were expressed in a prokaryotic high-level expression vector, sera produced against each purified recombinant protein and
used subsequently to probe Western blots and parasite sections. The leukocyte elastase inhibitor homologue and 2
unknowns induced significant proliferation by lymph node cells recovered from mice vaccinated with irradiated cercariae.
More strikingly, the 2 novel proteins stimulated very high levels of interferon c (IFNc) secretion both by lymph node cells
and those recovered by broncho-alveolar lavage from the lungs of vaccinated mice. Such results will be discussed in the
context of vaccine development.
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introduction
Despite coordinated international control pro-
grammes, schistosomiasis remains a major health
problem in many tropical and subtropical countries.
Approximately200 millionpeopleare infectedworld-
wide (Bergquist & Colley, 1998) and, despite a low
mortality rate and the existence of effective chemo-
therapy, 1 million deaths occur annually which can
be attributed to the direct or indirect effects of this
disease. For this reason, and the recent reports of low
drug efficacy (Ismail et al. 1996; Stelma et al. 1995),
a vaccine against schistosomiasis remains highly
desirable and is the ultimate goal of many research
projects.
A schistosome infection is initiated when the
water-borne cercarial stage encounters the skin of a
susceptible host. Mucous secretions enable the
parasite to adhere to the surface of the host while
proteases released from the acetabular glands digest
through the stratum corneum of the skin. In
addition, spines present on the surface of the cercaria
aid penetration. At this point, the cercarial tail is lost
and transformation into the next larval stage, the
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schistosomulum begins. This process involves pro-
found biochemical and morphological changes which
are vital for parasite survival within the mammalian
host. The material released by cercariae undergoing
transformation has been investigated previously at
the biochemical level by SDS–PAGE and auto-
radiography (Harrop & Wilson, 1993). This study
showed that radio-isotope labelled cercariae released
protein at a much greater rate during the first few
hours post-transformation than at later stages. Some
of the material lost at this early stage has been
characterized in more detail. For example, the
carbohydrate-rich glycocalyx which serves to water-
proof the cercaria has been analysed biochemically
(Xu et al. 1994), and the serine protease which
facilitates penetration through the epidermis and
dermis of the skin has been cloned, sequenced
(McKerrow et al. 1985) and immunolocalized
(Marikovsky, Fishelson & Arnon, 1988). In addition
to the protease, it has been demonstrated that
approximately 12 major proteins are released by
schistosomula during the first 3 h of transformation
(Mountford & Harrop, 1998), but the identity of the
majority of these remains unknown.
The molecules released during skin penetration
represent the first parasite proteins to which the
host’s immune system is exposed. An appropriate
effector response, induced by vaccination, against
one or more of these released proteins might interfere
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with the process of transformation}maturation or
facilitate clearance of the parasite at an early stage.
Following Francis & Bickle (1992), we have screened
expression libraries with rabbit antiserum raised
against the proteins released by transforming
cercariae and used it to confer passive protection to
mice challenged with S. mansoni. In addition, we
describe the cloning and sequence analysis of cDNAs
encoding proteins released by schistosomula during
the first 3 h post-transformation. A number of these
molecules have been subcloned into a high-level
expression vector and the purified proteins used
subsequently to produce sera. Such sera were used to
identify the full-length proteins in Western blot
analysis and to immunolocalize the molecules in
parasite sections. This study provides further insight
into the developmental biology of the parasite at a
highly critical stage of its life-cycle and details 4
molecules which have not been described previously
in S. mansoni. More importantly, in the context of
vaccine design and development, the ability of the
expressed recombinant proteins to induce lympho-
cyte proliferation and cytokine production has been
determined.
materials and methods
Preparation of parasite antigens
The life-cycle of S. mansoni was maintained in the
laboratory by routine passage through the inter-
mediate snail host Biomphalaria glabrata and MF1
mice. Soluble protein preparations of cercariae
(SCAP), lung-stage schistosomula (SLAP) and adult
worms (SWAP) and proteins released by skin-stage
schistosomula cultured in vitro during the first 3 h
post-transformation (0–3 hRPs) were produced as
described previously (Harrop & Wilson, 1993). The
released material was concentrated by centrifugation
in Ultrafree centrifugal filter devices (Millipore,
Watford, UK) containing 5 kDa cut-off membranes,
and the protein concentration determined subse-
quently by the Bradford assay.
Production of antisera to schistosomula-released
proteins and recombinant proteins
Antiserum against 0–3 hRPs was produced by
immunizing a rabbit subcutaneously with approxi-
mately 100 lg of the heterogeneous antigen prep-
aration emulsified in complete Freund’s adjuvant for
the primary inoculation and in incomplete Freund’s
adjuvant for the 2 subsequent boosts. The antibody
titre against 0–3 hRPs was assessed by ELISA (data
not shown) and deemed to be sufficient after 2
boosts. Antisera against purified recombinant
proteins were produced in a similar manner with the
exception that mice with a disrupted IFNc receptor
gene (129 IFNc Rw/w) were used. This mouse strain
was chosen because of the strong antibody response
induced upon vaccination. Approximately 10 lg
purified recombinant protein was administered per
mouse in both primary inoculations and in sub-
sequent boosts.
Western blotting
Proteins were separated electrophoretically through
12% polyacrylamide gels under reducing conditions
according to the method of Laemmli (1970). Re-
solved fractions were electroblotted onto
Immobilon-P membrane (Millipore) and probed
with sera as described by Cutts & Wilson (1997).
Passive transfer
Prior to transfer, both normal rabbit serum (NRS)
and serum raised in rabbits against 0–3 hRPs
(0–3 hS) were heat inactivated at 56 °C for 30 min.
Subsequently, the sera were incubated with 2 ml of
packed mouse red blood cells for 2 h at 37 °C to
adsorb potentially damaging antibodies directed
against murine antigens. For all passive transfer
experiments, groups of 5 C57BL}6 mice received
either NRS or test serum. In each case, mice were
exposed to a mean of 120 hand-counted cercariae via
the tail on day 0. Mice were divided into 4 groups
which received either NRS on day 0 (Group 1),
0–3 hS on day 0 (Group 2), 0–3 hS on day 1 (Group
3) or 0–3 hS on days 4 and 7 (Group 4). Groups 1
and 2, which received serum on day 0, were injected
several hours prior to challenge infection. For each
inoculation, 0–5 ml of serum was administered intra-
venously. Portal perfusion of the mice was carried
out 5 weeks after challenge infection and the adult
worm burden determined. Resistance was expressed
as the percentage reduction in the numbers of adult
worms recovered from mice receiving the test serum
compared to that of mice receiving NRS (Group 1),
and was calculated from the formula:
%Rfl (CfiT )}C‹100,
where Rfl level of resistance, Cflnumber of worms
recovered from the control group and Tflnumber
of worms recovered from the test group. Differences
in worm burdens were tested for statistical
significance using Student’s t-test.
Screening of cDNA libraries and sequence analysis
A cercarial cDNA library was screened essentially as
described by Huynh, Young & Davis (1986). The
primary serum (0–3 hS) was used at 1:1000 for
screening. Positive clones were isolated and purified
to homogeneity by several rounds of re-screening.
Plasmid DNA preparation and sequence analysis
was undertaken as detailed by Harrop, Coulson &
Wilson (1999).
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Table 1. Resistance of mice following a cercarial challenge on day 0
plus passive transfer of 0–5 ml of 0–3 hS on the days listed
(Worm burdens were determined following portal perfusion 5 weeks after chal-
lenge. Resistance compared to the NRS control group is shown and statistical
significance indicated in parentheses.)
Treatment
Mean worm
burden ‡ s.e.
Resistance compared to
NRS control group
NRS on day 0 51–7‡4.1 fi
0–3 hS on day 0 36–6‡2–7 29% (P!0–05)
0–3 hS on day 1 27–4‡2–1 47% (P!0–01)
0–3 hS on days 4 and 7 25–6‡3–7 51% (P!0–01)
Table 2. Summary of the predicted identity of cDNA clones
following homology searches of the GenBank and SwissProt databases
Clone identity Number Percentage
S. mansoni 21–7 kDa antigen 21 55–3
S. mansoni calcium-binding protein 11 29
S. mansoni glutathione-S-transferase 1 2–6
Homology to non-S. mansoni genes 2 5–3
No homology 3 7–8
High-level expression
A number of clones were selected for expression in a
prokaryotic high-level expression system. The
cDNA inserts were subcloned into the pQe ex-
pression vector and then used to transform com-
petent E. coli M15 cells. In addition to the schisto-
some molecules, b-galactosidase cDNA was ligated
into the pQe vector. Expression and subsequent
purification of recombinant proteins was undertaken
according to the protocols provided by Qiagen. The
histidine-tagged proteins were purified under
denaturing conditions by Ni-NTA resin chromato-
graphy. Where required, purified proteins were
dialysed extensively against decreasing concen-
trations of urea and finally against phosphate-
buffered saline, pH 7–2.
Immunocytochemistry
Cercariae, lung-stage schistosomula and adult
worms were prepared for immunocytochemistry
based on the methodology developed by
Riengrojpitak et al. (1989) and as detailed by Harrop
et al. (1999).
Assays of lymphocyte proliferation and cytokine
production
Assays were undertaken as described by Mountford,
Harrop & Wilson (1995) and more specifically by
Harrop et al. (1999). Results illustrated are rep-
resentative of 2 (lung) or 3 (lymph node) individual
experiments. Where appropriate, the mean‡s.d. is
plotted.
results
Passive transfer
0–3 hS was transferred to naı$ve mice on various days
to assess the importance of skin- and lung-stage
parasites as targets of immune elimination by
antibodies reacting with antigens released during
transformation. The mean worm burdens and calcu-
lated resistance values compared to the NRS control
group are illustrated in Table 1. Mice in all 3 test
groups showed statistically significant levels of
protection compared to controls (a single control
group was used in order to reduce the numbers of
animals). Mice receiving serum on day 1 or days 4
and 7 showed the most significant reduction in worm
burdens (47% and 51% respectively).
cDNA library screening
By screening approximately 3‹10& plaques in the
cercarial cDNA library, 38 positive clones were
identified. Each was picked and subsequently puri-
fied to homogeneity after several rounds of re-
screening. Plasmid preparations of each clone pro-
vided the template for sequence analysis. A summary
of the clones identified following single-pass
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Fig. 1. Lineup of Clone 8 and the leukocyte elastase inhibitors of humans, horses and pigs. Identities are illustrated
in the consensus line and gaps introduced (.) to optimize the alignment.
sequencing from the 5{ end, is given in Table 2.
Previously identified schistosome genes, including
the 21–7 kDa antigen (U30663), calcium-binding
protein (J04641; Ram et al. (1989)), and glutathione-
S-transferase (S71584; Pierce et al. (1989),
accounted for the vast majority of positive clones
identified (approximately 85%). The remaining
positive clones included 2 which had homology to
non-schistosome genes and 3 which had no hom-
ology to anything present in the databases.
Full-length sequence analysis
Full-length sequence analysis of all 5 novel schisto-
some clones was undertaken by primer walking from
both 5{ and 3{ ends.
(a) Clones 13, 19 and 24 (Accession numbers:
AF030971, AF030973 and AF030974 respectively).
Despite obtaining complete sequences of the partial
cDNA fragments present in clones 13, 19 and 24, no
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Fig. 2. Western blots of the target recombinant protein
alongside SCAP, SLAP and SWAP probed with sera
against (A) r8, and (B) r24. Five lg soluble protein
preparations and 0–5 lg recombinant protein were loaded
per lane. Molecular weights are illustrated.
homologies were identified to any molecule
sequenced to date. The clones had cDNA inserts of
446, 409 and 601 bp respectively which contained
open reading frames of 37, 68 and 127 aa.
(b) Clone 8 (Accession number: AF030970). Clone 8
contains an insert of 866 bp which was sequenced
from both 5{ and 3{ ends and the fragments aligned to
yield the complete cDNA sequence. The single open
reading frame of 256 aa encodes a protein of
predicted molecular weight 29 kDa and pl of 5–05.
Searches of SwissProt showed the molecule to have
significant homology to many proteinase inhibitors,
but particularly with the leukocyte elastase inhibitors
of horses (P05619), humans (P30740) and pigs
(P80229). Identities of 29, 28 and 26% occur over a
173 aa overlap in the 3 proteins respectively. If
conservative substitutions are taken into consider-
ation, the homology reaches 49%. A lineup of clone
8 and these 3 elastase inhibitors is illustrated in Fig.
1. The homology occurs at the N-terminal end of the
proteins and within this region, only 3 gaps in the
mammalian enzymes and 2 gaps in clone 8 are
required for optimal alignment. No poly A tail is
evident in the nucleic acid sequence suggesting that
clone 8 is incomplete at the 3{ end. The 5{ end
contains a methionine at amino acid position 11, but
it is difficult to determine whether this represents the
start codon of the parasite molecule. The sequence of
clone 8 appears to be distinct from those of the serpin
family.
(c) Clone 16 (Accession number: AF030972). Clone 16
contains an insert of 285 bp and a deduced open
reading frame of 52 aa which ends at 158 with a
UGA stop codon. The molecule has a predicted
molecular weight of 6–5 kDa and a pI of 9–2. Searches
of SwissProt showed the clone to have significant
homology with many cytochrome C molecules.
Identities of 71% over a 28 aa overlap occurred in all
proteins, predominantly at the C-terminal end. In
addition, clone 16 showed very high homologies to
many schistosome ESTs (including a number de-
rived from cercariae) listed as being homologous to
cytochrome C molecular species.
Identification of the full-length proteins in different
life-cycle stages
Clones 8, 13, 19 and 24 were expressed in the pQe31
expression vector. Sera produced against each recom-
binant protein (r8, r13, r19 and r24) were used
subsequently to probe Western blots of the recom-
binant protein as well as soluble preparations of
cercariae, lung-stage schistosomula and adult worms
(SCAP, SLAP and SWAP respectively). Sera against
r13 and r19 were capable of detecting the recom-
binant against which they were raised, but did not
bind to any other proteins in the soluble preparations
(data not shown). Western blots probed with anti-r8
and anti-r24 are illustrated in Fig. 2(A and B).
Serum against r8 (Fig. 2A) appeared to bind a range
of molecules in the recombinant protein fraction
purified from a bacterial lysate. Presumably, these
represent multimers and breakdown products of the
recombinant. However, when used to probe blots of
SCAP, SLAP and SWAP, the serum bound strongly
to a doublet at 43 and 47 kDa in the 2 earlier life-cycle
stages. Serum against r24 (Fig. 2B) bound to a single
protein of 25 kDa in both the recombinant and
SCAP fractions. No proteins were detectable in
SLAP or SWAP.
Immunolocalization
Sera against the 4 recombinant proteins were used to
probe sections of cercariae, lung worms and adult
worms. The results are shown in Fig. 3(A–F).
Proteins 13 and 24 appeared to be most abundant in
muscle while 8 and 19 showed a more diffuse
distribution, being present in muscle but also many
other tissues. Clone 19 also appeared to be located in
discrete, intensely staining foci in the lung worm; it
is possible that these are flame cells of the parasite’s
excretory}secretory system.
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Fig. 3. Immunolocalization of clones 8 (A and B), 13 (C and D), 19 (E) and 24 (F) in sections of cercariae (A and E),
lung-stage schistosomula (C and F) and adult worms (B and D).
Lymphocyte proliferation and cytokine production
The ability of recombinant proteins 8, 13, 19 and 24
to induce lymphocyte proliferation and cytokine
production by cells recovered from mice at day 5
(lymph node) or day 21 (lung) post-vaccination was
determined. Comparisons were made to 2 pure, non-
schistosome proteins (BSA and b-galactosidase),
which served as negative controls and a soluble
schistosome preparation (SCAP) which was used as
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Fig. 4. Proliferative responses (A) and IFNc production (B and C) by cells recovered from the axillary lymph nodes
of mice 5 days after vaccination with irradiated cercariae (A and B) and from the lungs of mice 21 days post-
vaccination. Cells were used at a concentration of 1‹10& per well and antigen at 5 lg}ml. Proliferative responses are
expressed as cpm‡s.d. from triplicate wells. These are representative results from 3 separate experiments. IFNc
production is expressed as pg}ml following extrapolation from a standard curve.
a positive control (Fig. 4A, B and C). All 4
recombinant proteins induced greater levels of
proliferation than that seen with either medium
alone, BSA or purified recombinant b-gal (Fig. 4A).
Recombinants 8, 24 and particularly 19 caused
proliferation approaching that seen with SCAP.
Interferon c production by the same lymph node
cells on day 3 is illustrated in Fig. 4B. Cytokine
production following stimulation with r8 was no
different from that induced by BSA or b-galacto-
sidase. In contrast, r13 and r19 caused higher
levels of IFNc secretion while r24 yielded "700 pg
IFNc}ml. No IL-4 secretion was detectable. When
cells recovered from the lungs of mice 21 days post-
vaccination were restimulated in vitro with the
same antigens (Fig. 4C), all caused greater IFNc
secretion than the negative control antigen b-gal.
Recombinants 8, 19 and 24 induced significantly
more IFNc production than did the heterogeneous
protein preparation SCAP. Indeed, r24 caused IFNc
to be secreted at a concentration approaching
13000 pg}ml.
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discussion
By using serum raised against 0–3 hRPs, we have
been able to transfer resistance against a cercarial
challenge to naı$ve mice. Although the use of rabbit
serum in a murine model represents a heterologous
system, the binding of antibodies present in the
serum to parasite-derived molecule(s) renders the
schistosomulum sensitive to immune-mediated
clearance. Paradoxically, the serum, which was
raised against skin-stage released proteins, was most
efficient at conferring passive immunity when trans-
ferred at a time coincident with parasite residence in
the lungs. This suggests that some of the proteins
released by transforming cercariae are still expressed
by lung worms. Likewise, sera from rabbits (Bickle
et al. 1985; Mangold & Dean, 1992) and mice
(Mangold & Dean, 1986) which had been multiply
vaccinated with irradiated cercariae were equally, or
more highly protective when serum transfer
coincided with parasite residence in the lungs, rather
than the skin stage of migration. It is possible that
the lungs may simply represent a site in which the
schistosomulum is stationary for several days while
it undergoes adaptation necessary for further mi-
gration and is therefore more prone to immune
attack. We cannot discount the possibility that mice
receiving serum on day 0 or day 1 are clearing a
proportion of the parasite challenge at the skin-stage.
However, this is clearly not essential for the transfer
of optimal resistance since when serum was trans-
ferred on days 4 and 7, few parasites would still be
present in the skin (Wilson, Coulson & Dixon,
1986). Although the mechanism of schistosome
elimination is not known, we must assume that
antibodies are binding to accessible proteins on the
surface of the challenge parasite or generating
immune complexes with released proteins leading to
inflammation. Inhibition of essential parasite pro-
cesses or binding of cells bearing Fc receptors could
result in killing. It is impossible to determine which
of the 0–3 hRPs is the target of the protective
antibodies transferred to naı$ve mice. However, we
have shown here that the vaccine antigen GST was
detected following screening of a cercarial cDNA
library with serum raised against 0–3 hRPs. In this
respect, it has been demonstrated previously that
monospecific serum against GST could transfer
resistance against a cercarial challenge in mice
(Balloul et al. 1987). We do not know if this also
occurs in our experimental system and therefore
could be partially or wholly responsible for the
protection observed. The importance of antibodies
in protective immune responses to S. mansoni
remains a matter of conjecture. In the irradiated
cercaria vaccine model, antibodies are thought to
have little importance in 1 time vaccinated mice
(Anderson et al. 1999). However, in mice capable of
making a strong Th2 type response (e.g. IFNcRw/w
mice), antibodies do play a protective role following
multiple vaccination (Coulson & Wilson, unpub-
lished data).
By screening a cercarial library with serum raised
against 0–3 hRPs, we sought to identify cDNA
clones encoding secretory molecules involved in the
processes of skin penetration and parasite trans-
formation. Several criteria were applied to determine
whether this goal had been achieved, including the
presence of a putative signal sequence, homology to
known secretory proteins and immunolocalization of
the molecule. In total, 38 clones encoding 8 different
molecules were identified. By far the 2 most
abundant molecules detected by library screening
were the 21–7 kDa antigen and calcium-binding
protein which together represented almost 85% of
the positive clones identified. This may be due to
either the presence of high titre and}or affinity
antibodies in the serum or a high frequency of the
specific cDNAs in the library. In this respect, by
using the same cercarial library as a source of ESTs,
Franco et al. (1997) showed that the calcium-binding
protein represented 10% of the total useful clones.
Clone 8 appears to encode a schistosome hom-
ologue of mammalian leukocyte elastase inhibitors
(LEIs). The cDNA insert is not complete since there
is no poly A tail and serum against r8 binds 2
proteins of 43 and 47 kDa in SCAP and SLAP,
although the predicted molecular weight of the
0–86 kBa insert is 29 kDa, further suggesting that
only a fragment is present. The LEIs of humans,
horses and pigs are of molecular weight 42–7, 43 and
42–6 kDa respectively. We can only speculate on the
role this molecule may play in the parasite. It is
possible that the protein regulates the serine elastase
which is released during skin penetration. This
potent protease may need to be tightly controlled to
avoid damaging the parasite itself. However, if this
were the case, why the molecule has greatest
homology to mammalian molecules is difficult to
explain. Another possibility is that the protein has a
defensive role and acts to inhibit enzymes released
by host leukocytes.
Clones 13, 19 and 24 show no homology to any
molecule sequenced previously. Each seems to have
an intact poly A tail, but an incomplete 5{ end. Thus,
it is not possible to search for putative signal
sequences which might provide circumstantial evi-
dence that the molecule was secreted. In addition,
we can say little about the size and distribution of the
‘native’ proteins representing clones 13 and 19 in
different parasite life-cycle stages as Western blot-
ting with each serum was not successful. Since each
serum was capable of detecting the recombinant
against which it was raised, we presume that the
inability to bind proteins in soluble parasite fractions
is due to either low abundance of the molecule in
these preparations or poor sensitivity of the serum.
Using the sera to probe blots of 0–3 hRPs may prove
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more successful, although the highly glycosylated
nature of this preparation makes clean Western blots
difficult to achieve. Serum against r24 binds a single
protein which is only detected in SCAP by Western
blotting, suggesting that it either exhibits stage-
specific expression, or is highly represented in
cercariae compared to later life-cycle stages. How-
ever, immunofluorescence studies suggest that the
protein is also present in adult worms (data not
shown). Since the molecular weight of the recom-
binant and the ‘native’ protein are identical, this
would suggest that clone 24 is full-length although,
from the nucleotide sequence, it is difficult to predict
where the start codon might be. It is possible that the
clone is missing the extreme 5{ end which includes
the start methionine.
Immunofluorescence studies do not provide com-
pelling evidence that the molecules we have cloned,
sequenced and expressed encode secretory proteins
since none of the sera stained the acetabular glands of
the cercaria. However, the process by which proteins
are released during cercarial transformation must be
considered. Vesicles, originating from the acetabular
glands, are released in large numbers on to the
surface of the host ; this process is readily observed in
vitro by light microscopy. Upon contact with skin
(or in vitro with the plastic tissue culture flask), the
vesicles burst releasing their contents. The majority
of molecules described here are likely to include
contents of such vesicles released by the process of
holocrine secretion. This does not diminish the
importance of these proteins, since they are the first
molecules to which the host’s immune system is
exposed. We may have limited the number of
different clones identified in this study by screening
only a cercarial library. It is likely that a number of
the proteins expressed at this transitional point of the
parasite life-cycle are only required at this specific
stage. For example, the cercarial elastase which is
essential for parasite transformation and skin pen-
etration, is only expressed for a few days in the
schistosomulum, and the gene only transcribed in
the sporocyst. Thus, mRNA encoding this enzyme
would not be represented in the cercarial library.
Other constituents of the acetabular glands may also
fall into this category.
The degree of proliferation and IFNc secretion by
cells recovered from lymph nodes and lungs of
vaccinated mice following restimulation with 3 of the
purified recombinant antigens was very high. Sec-
retion of the Th1-type cytokine IFNc by cells,
recovered from the lungs of vaccinated mice, after
stimulation with r8, r19 and r24 greatly exceeded
that observed in response to the heterogeneous
soluble preparation. Considering the number of
antigens present in SCAP and therefore the number
of T cell epitopes compared to a single recombinant
protein, this is perhaps surprising. In addition, we
have demonstrated previously that the hetero-
geneous mixture of proteins released during the first
3 h after cercarial transformation induced the lowest
level of IFNc secretion by cells recovered from
vaccinated mice when compared to other parasite
preparations (Mountford, Harrop & Wilson, 1995).
When compared to recombinant proteins represen-
tative of a subset of lung-stage schistosomula
released proteins (Harrop, Coulson & Wilson, 1999),
r19 and r24 induce greater levels of IFNc secretion
by cells recovered from the lungs of vaccinated mice.
We have shown r24 to be highly represented in
cercariae compared to later life-cycle stages as
determined by Western blotting. This would suggest
that its release from the parasite soon after pen-
etration results in large-scale priming and expansion
of specific Th1 cells which are recruited subse-
quently to the lungs. The much greater levels of
IFNc secretion by cells recovered from the lungs,
compared to the lymph nodes, of vaccinated mice
could be due to several factors such as the pref-
erential expansion or recruitment of schistosome-
specific Th1 cells to the lungs. Since we have shown
that little or no proliferation of parasite-specific T
cells occurs in the lungs (Smythies & Wilson,
unpublished observations), we would suggest that
their preferential recruitment to this site is re-
sponsible for the enhanced IFNc secretion.
The cloning and sequence analysis of the proteins
released by transforming cercariae provides further
insights into the developmental biology of the
parasite at a crucial stage in its life-cycle. More
importantly, we have shown that a number of the
novel molecules are potent immunogens, inducing a
strong Th1-type response. Since the secretion of
high levels of IFNc in the lungs of 1 time vaccinated
mice is essential for the expression of resistance
following cercarial challenge (Smythies, Coulson &
Wilson, 1992), these results are encouraging when
considering vaccine development. Further work will
assess the potential of these proteins as vaccine
candidates.
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